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Abstract
Background: Calcium (Ca) is a well-known element in bone metabolism and blood coagulation. Here, we
investigate the link between the protein adsorption pattern and the in vivo responses of surfaces modified with
calcium ions (Ca-ion) as compared to standard titanium implant surfaces (control). We used LC–MS/MS to identify
the proteins adhered to the surfaces after incubation with human serum and performed bilateral surgeries in the
medial section of the femoral condyles of 18 New Zealand white rabbits to test osseointegration at 2 and 8 weeks
post-implantation (n=9).
Results: Ca-ion surfaces adsorbed 181.42 times more FA10 and 3.85 times less FA12 (p<0.001), which are factors of
the common and the intrinsic coagulation pathways respectively. We also detected differences in A1AT, PLMN,
FA12, KNG1, HEP2, LYSC, PIP, SAMP, VTNC, SAA4, and CFAH (p<0.01). At 2 and 8 weeks post-implantation, the mean
bone implant contact (BIC) with Ca-ion surfaces was respectively 1.52 and 1.25 times higher, and the mean bone
volume density (BVD) was respectively 1.35 and 1.13 times higher. Differences were statistically significant for BIC at
2 and 8 weeks and for BVD at 2 weeks (p<0.05).
Conclusions: The strong thrombogenic protein adsorption pattern at Ca-ion surfaces correlated with significantly
higher levels of implant osseointegration. More effective implant surfaces combined with smaller implants enable
less invasive surgeries, shorter healing times, and overall lower intervention costs, especially in cases of low quantity
or quality of bone.
Keywords: Titanium implants, Osseointegration, Blood coagulation, Implant surface design, Protein adsorption
Background
Titanium (Ti) is the preferred material for biomedical
applications because of its balance of mechanical
properties, corrosion resistance, biocompatibility, and
osseointegration [1]. Implant surface characteristics play
a crucial role in the physiological acceptance of im-
planted materials. Many surface modifications have been
proposed aiming at improving implant osseointegration.
These modifications gravitate mainly around roughness
and/or oxide composition and, more recently, incorpor-
ate bioactive agents to the surfaces [2]. Research in this
field has led to the development of implant surfaces
modified with specific molecules and bioinorganic ions
that enhance the intrinsic osteogenic capacity of Ti,
leading to specific physical and biochemical responses in
the bone tissue around the implant [3, 4].
The first biological process that takes place upon im-
plant placement is blood protein adsorption and the
formation of a blood clot onto the biomaterial surface.
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These processes are modulated by material’s physico-
chemical properties such as chemical composition, sur-
face morphology, and charge [5]. Advances in the
knowledge of the molecular and biochemical pathways
involved in bone regeneration show the importance of
elements such as calcium, strontium, magnesium, or
zinc [6, 7]. Calcium (Ca) ions, for example, promote and
accelerate blood coagulation leading to the formation of
the prothrombinase complex, which converts prothrom-
bin into thrombin and, thereby, fibrinogen into fibrin [8–
10]. The characteristics of the fibrin architecture of the
blood clot are relevant to give shape and function to the
forming implant-surface scaffold that mediates the adhe-
sion, proliferation, and differentiation of cells [11, 12]. Ca-
ion signaling plays also an important role in the osteoblast
differentiation process, being crucial to stimulate osteo-
blast differentiation and increase osteogenesis by regulat-
ing osteocalcin, bone sialoprotein, osteopontin, ALP, and
BMP-2 expression in mesenchymal stem cells [13].
Thus, the composition of the adsorbed protein layer
plays a pivotal role in the initiation and progress of bio-
logical responses occurring after implantation. Proteins
forming part of this layer initiate and regulate processes
such as potential foreign body response, inflammation,
coagulation, and fibrinolysis and even bone cell activity
in the earlier stages of osteogenesis [11, 14]. Conse-
quently, the interaction of the biomaterial when exposed
to serum proteins can provide preliminary clues to im-
plant designers as to what compositions are more likely
to be rejected/accepted by the host, as previously dem-
onstrated in vitro [15, 16] and in vivo [14, 17, 18].
In this work, we aim at evaluating the protein adsorp-
tion patterns and in vivo osseointegration at regular Ti
implant surfaces compared to surfaces with adsorbed
Ca-ions. We hypothesize that differential surface protein
adsorption profiles in vitro may lead to differences in
bone implant integration in vivo. Among the animal
models for implant osseointegration, the rabbit has
been widely employed in the past because of its fast
skeletal change and human-like mineral density [19,
20]. When the implantation is made in the femoral
condyles, the implants and peri-implant tissues are
mechanically stimulated within a less dense trabecular
bony architecture, which represents a favorable sce-
nario to test more performing implant developments
in challenging situations [21].
Methods
Substrates
We prepared the surfaces out of machined CP titanium
grade IV on two different geometries: (1) 12.7-mm
diameter and 1-mm thick discs and (2) custom-made cy-
lindrical implants with a top 2-mm diameter × 4-mm
long part and a bottom 4-mm diameter × 2-mm long
part (like a T upside-down) for in vivo testing.
The control and Ca-ion surfaces were prepared ac-
cording to the protocols described in Anitua et al. [4].
Briefly, we roughened the samples’ surfaces by sequential
acid etching and further cleaning and conditioning in a
class A clean room (BTI Biotechnology Institute S.L.,
Vitoria, Spain). The control surfaces were no further
modified, and the Ca-ion surface was prepared according
to a proprietary process (unicCa®) from the control sur-
faces. Briefly, Ca-ion surfaces were prepared by dip coat-
ing during 30 s in a bath containing 5 wt% CaCl2 in a
clean room class A. We β-ray sterilized all the samples
and stored them until use. In addition to these two sur-
faces, Ca-ion surfaces after immersion for 5 s in deion-
ized water and let air dry (Ca-ion diluted) were prepared
to assess the morphology of the topography underlying
the hydrated CaCl2 layer. We took representative scan-
ning electron microscopy (SEM) micrographs of the sur-
faces at different magnifications with a Quanta 200FEG
SEM (FEI Eindhoven, The Netherlands) at 30 kV accel-
eration voltage and 3 Å spot size.
Surface characterization
We used the SEM Phenom Pro-X (Phenom-World BV,
Eindhoven, The Netherlands) software (Phenom Pro
Suite) to acquire images and quantity of the surface
morphology by reconstructing its 3D surface, from
which mean surface roughness values (Sa) were calcu-
lated. Sa is the arithmetic mean of the absolute devia-
tions of the roughness profile from the mean plane. We
applied two cutoff filters: 20×20 nm to 20×20 μm and
10×10 μm to 50×50 μm in order to separate the Sa
roughness values (Sar) and the Sa waviness values (Saw)
respectively from the primary (Sap) unfiltered values.
Three different areas of 270 μm2 of each sample were
selected for 3D reconstruction and calculation. Results
were averaged from three measurements per surface
condition and substrate geometry.
To analyze the composition of Ca-ion and control sur-
faces, we used the energy dispersive X-ray spectroscopy
(EDS) equipped in the SEM Phenom Pro-X. The unit
has a thermoelectrically cooled silicon drift detector and
a narrow Si3N4 window for elemental detection. We
scanned areas of 270 μm2 at ×1000 magnification and 15
kV acceleration voltage to maximize EDS yield. We used
three samples per surface type and geometry.
Adsorbed protein layer
We incubated the control and Ca-ion samples in a 24-
well NUNC plates (Thermo Fisher Scientific, Waltham,
MA, USA) for 3 h (37 °C, 5% CO2) with 1 mL of human
blood serum from male AB plasma (Sigma–Aldrich,
Merck KGaA, Darmstadt, Germany). In order to allow a
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standard, replicable characterization, we used commer-
cial human serum as previously described in Romero-
Gavilán et al. [22]. After 3 h incubation, we removed the
serum and washed the discs five times with ddH2O and
once with 100 mM NaCl, 50 mM Tris–HCl (pH 7.0) to
eliminate non-adsorbed proteins. We collected the
adsorbed protein layer by washing the discs with an elu-
tion (0.5 M triethylammonium bicarbonate buffer
(TEAB), 4% of sodium dodecyl sulfate, 100 mM of
dithiothreitol (DTT)). We carried out four independent
experiments for each type of surface, and we used four
discs of each surface type in each experiment. We used
a Pierce BCA assay kit (Thermo Fisher Scientific,
Waltham, MA, USA) to quantify the serum protein con-
tent, which was 50 μg/μL.
Proteomic analysis
We performed the proteomic analysis as described by
Romero-Gavilán et al. [22] with minor variations. Briefly,
we digested the eluted protein in-solution, following the
FASP protocol established by Wiśniewski et al. [23] and
loaded onto a nanoACQUITY UPLC system connected
online to an LTQ Orbitrap XL ETD (Thermo).
We analyzed each surface in quadruplicate. We used
the Progenesis software (Nonlinear Dynamics, Newcas-
tle, UK) to perform the differential protein analysis using
as described before [24]. We used the DAVID GO
(https://david.ncifcrf.gov/) and Panther classification sys-
tem (http://www.panth erdb.org/) for the functional an-
notation of the proteins.
Surgical procedure
We used nine implants (n=9) per surface type (control
and Ca-ion) and defined the evaluation time at 2 and 8
weeks post implantation. We inserted the implants bilat-
erally in the medial femoral condyle of 18 New Zealand
white female rabbits. The rabbits were skeletally mature,
aged 23 ± 2 weeks, and weighed 3.2±0.7 kg. Following
sedation and anesthesia, we administered a preoperative
antibiotic. We made the incision through the skin, the
muscular fascia, and sartorius muscle, exposing the su-
perior distal quadrant of the medial condyle for implant-
ation. To prepare the implant sites, we used drills of 2.5
and 4.2 mm under thorough saline irrigation. Prior to
implant installation by press-fit, we cleaned the implant
site from drilling remnants. We sutured the tissues in
layers. After surgery, the rabbits received analgesia
(Metacam, 0.2 mg/kg, subcutaneous) and antibiotics
(cefazoline 0.2 mg/kg, intramuscular) for 4 days. We
monitored on a daily basis the animals’ weight, behavior,
and health conditions. After 2 and 8 weeks of implant-
ation, the animals were euthanized.
We performed all procedures following the ISO
10993-6:2016 (Annex D). We handled the animals and
performed the surgeries according to the directive of the
European Parliament and Council of the European Com-
munities (2010/63/EU) and the Spanish legislation (RD
1201/2005 and Law 32/2007). The ethics committee of
the Autonomous Government of Aragón (Spain) ap-
proved the protocol of this study and certified the fulfill-
ment of animal welfare guidelines (file number PI26/12).
The study has been carried out in compliance with the
ARRIVE EQUATOR guidelines.
Histological evaluation and histomorphometry analysis
After sacrifice, we extracted the condyles and fixed the
implants with the surrounding bone in 4% buffered
formalin solution for at least 24 h. The condyles with
the implants were dehydrated in ethanol from growing
concentrations from 70 to 100% and embedded in a
light-curing acrylic resin (Technovit 7200 VLC,
Heraeus-Kulzer, Wehrheim, Germany) according to the
manufacturer’s instructions. Following polymerization,
we cut the blocks to a thickness of 300 μm and polished
them to their final thickness. We got two non-
decalcified 20-μm-thick sections of the implants follow-
ing their longitudinal axis using a diamond microtome
saw (Exakt Technologies, Oklahoma City, USA). We
stained the sections with Harris hematoxylin and
Wheatley’s trichromatic stain and examined them at dif-
ferent magnifications with a Leica DMLB light micro-
scope (Leica Microsystems, Wetzlar, Germany) coupled
to a Leica DFC300FX digital camera. The ground sec-
tions were observed at ×2.5, ×5, and ×20.
We performed a blind histomorphometry analysis to
quantify the bone response and osseointegration around
the 4-mm diameter × 2-mm long bottom part of the im-
plants. The top part of the implant was discarded in
order to prevent undesired data noise coming from
slightly different implant placement heights and from
the more variable regenerative situation near the soft tis-
sues. We took the measurements with a ×5 objective,
and we calculated the bone to implant contact (BIC) and
bone volume density (BVD) percentages with the soft-
ware ImageJ 1.47 (National Institutes of Health, Be-
thesda, MD, USA). BIC refers to the contour of direct
bone-implant contact without interposition of fibrous
tissue and BVD to the area occupied by bone tissue in
the 1 mm region closer to the surface.
Statistical analysis
We confirmed data normality prior to comparisons
(Shapiro–Wilk) and expressed them as mean ± standard
deviation (SD). We determined the differences between
the means by two-sample independent Student’s two-
tailed homoscedastic t-test between surfaces. We consid-
ered statistical significance for p<0.05. We used Origin
v7.5 (OriginLab Corporation, Northampton, MA, USA)
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for all statistical analyses except for the proteomic data,
for which we used the Progenesis QI software. We con-
sidered differential protein adsorption for p<0.05 and a
ratio higher than 1.5 in either direction.
Results
The implant surfaces
Figure 1 shows representative SEM images of the control
(a, b) and Ca-ion before (c, d) and after dilution (e, f).
The Ca-ion-diluted surface is similar to the control: both
show the typical micron (a, e) and sub-micron (b, f) sur-
face features of these implant surface preparations. At
the Ca-ion surface (c, d), the vacuum produced in the
chamber of the SEM dehydrates the CaCl2 layer and re-
sembles a coating embedded within the surface
roughness.
Table 1 shows the unfiltered (Sap), roughness (Sar), and
waviness (Saw) filtered topographical parameters of the
surfaces. The control and the Ca-ion-diluted surfaces
show no significant differences in any roughness values,
while the dehydrated deposit of CaCl2 inside the SEM
chamber fills the pits of the roughness and produces
thus a significant reduction in all roughness values with
respect to the control or the Ca-ion diluted.
EDS spectra corresponding to the control surfaces
(Fig. 2) yielded 68.5±5.3 At% associated with titanium
and 31.6±7.3 At% associated with oxygen. Carbon was
below the detection limit, typically below 2 At%. Ca-ion
surfaces’ spectra contained 48.4± 5.2 At% oxygen, 32.4±
4.8 At% titanium, 12.8±2.2 At% chlorine, and 6.6±2.3
At% calcium.
The protein adsorption
We analyzed the eluted proteins by LC-MS/MS and
performed a comparative analysis between the data
for each surface with Progenesis. Table 2 shows the
main results of the analysis carried out comparing
control and Ca-ion surfaces. Raw data is shown in
Table S1. Seventeen proteins were differentially
absorbed by the Ca-ion surface, wherein four were
more absorbed and 13 presented less affinity with this
material. The surface treatment led to a significant in-
crease of one protein related with coagulation (FA10)
and three related with immune responses (LYSC, PIP,
and SAMP). Five proteins related with coagulation
processes (A1AT, PLMN, FA12, KNG1, and HEP2)
Fig. 1 Representative SEM micrographs of the control (a, b) and the and Ca-ion surfaces before (c, d) and after dilution (e, f). Magnifications
×2500 (a, c, e) and ×40,000 (b, d, f)
Table 1 Roughness of control and Ca-ion surfaces before and
after dilution. Data is shown in nm ± standard deviation
Control Ca-ion Ca-ion diluted
Sap 2320 ± 242 1080 ± 92 2040 ± 259
Sar 1021 ± 122 612 ± 70 1069 ± 144
Saw 1553 ± 172 678 ± 56 1423 ± 215
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and three related with immune responses (VTNC,
SAA4, and CFAH) were less adsorbed at Ca-ion sur-
faces. APOE, which plays an important role in bone
metabolism by allowing the entry of vitamin K into
the osteoblasts to carry out the carboxylation of
osteocalcin, was found in highest proportion attached
onto Ti. Also, TRFE, a protein, linked to the anchor-
ing and transport of Fe3+, DHX8, with functions in
RNA processing and two proteins related to ATP syn-
thesis (ATPA and ACTBL).
The DAVID and Panther systems were used to associ-
ate the adsorbed proteins with their functions in distinct
biological pathways (Figure S1). In control surfaces (a),
we identified proteins associated with ATP synthesis,
plasminogen-activating cascade, Huntington and Alzhei-
mer diseases, inflammation mediated by chemokine
and cytokine, integrin and cadherin signaling path-
ways, cytoskeletal regulation, and blood coagulation.
In Ca-ion surfaces (b), the only function identified
was blood coagulation.
In vivo osseointegration
Because of exitus of rabbit number 13, two implants,
one of each surface, were not available for analysis. The
post-operative period was uneventful for all remaining
rabbits. We analyzed then nine implants per surface type
at 2 weeks and eight implants at 8 weeks. Supplementary
tables 2, 3, 4 and 5 show all the data obtained.
Figure 3 shows the results of the bone implant con-
tact (BIC) and bone volume density (BVD) of the con-
trol and Ca-ion surfaces at 2 and 8 weeks after
implants placement. At 2 weeks of healing, the BIC
percentage of the control and the Ca-ion surfaces was
31.4±16.5% and 47.9±7.6%, respectively (p=0.016, Table
S2); the BVD% was 34.4±8.2% and 46.6±7.0%,
Fig. 2 EDS spectra of the control (a) and the Ca-ion (b) surfaces
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respectively (p=0.004, Table S4). At 8 weeks, the BIC
percentage increased to 43.2±8.1% and 53.8±9.5%, re-
spectively (p=0.028, Table S3), but the BVD percentage
decreased to 28.3±6.5% and 32.0±5.0%, respectively (p=
0.195, Table S5).
Figures 4 and 5 show representative histological
ground sections of the implants. The histological evalu-
ation showed no sign of inflammatory response or com-
plication, and all implants osseointegrated correctly. The
Harris hematoxylin and Wheatley’s trichromatic stain
showed immature unorganized bone with elevated
osteoblastic activity in red tones, while light purple
staining showed the parent mature bone.
At 2 weeks, we observed high bony activity near the sur-
faces (Fig. 4). There was a clear separation (marked with a
black line) between the drilled region near the implant
surface, in which new bone (NB) formation was taking
place, and the parent bone (PB) with the pre-existing bony
architecture (Fig. 4 c and d). We found poorly mineralized
bone in the NB area (bright red staining) with high osteo-
blastic activity in the marginal areas and near the implant
surfaces (Fig. 4a.1). White arrows in a.1 show high
Table 2 Differential Ca-ion/control adsorbed protein ratio. Data with ANOVA p < 0.05 and a ratio higher than 1.5 in either direction
was considered as significantly different
Accession Description p value Ratio
FA10_HUMAN Coagulation factor X 1.13E−04 181.42
LYSC_HUMAN Lysozyme C 2.29E−02 13.60
PIP_HUMAN Prolactin-inducible protein 3.90E−02 2.98
SAMP_HUMAN Serum amyloid P-component 4.66E−02 2.59
A1AT_HUMAN Alpha-1-antitrypsin 3.97E−03 0.53
TRFE_HUMAN Serotransferrin 1.69E−02 0.46
VTNC_HUMAN Vitronectin 2.13E−02 0.45
APOE_HUMAN Apolipoprotein E 4.78E−03 0.41
SAA4_HUMAN Serum amyloid A-4 protein 3.45E−02 0.38
PLMN_HUMAN Plasminogen 1.10E−02 0.28
FA12_HUMAN Coagulation factor XII 4.26E−02 0.26
KNG1_HUMAN Kininogen-1 1.16E−04 0.24
ATPA_HUMAN ATP synthase subunit alpha mitochondrial 3.56E−02 0.24
ACTBL_HUMAN Beta-actin-like protein 2 3.65E−02 0.19
DHX8_HUMAN ATP-dependent RNA helicase DHX8 4.11E−02 0.13
HEP2_HUMAN Heparin cofactor 2 4.92E−02 0.13
CFAH_HUMAN Complement factor H 1.28E−02 0.06
Fig. 3 Bone implant contact (BIC; a and b) and bone volume density (BVD; c and d) in percentage (%) of control and Ca-ion surfaces after 2 and
8 weeks of implantation from two ground sections of each of the 36 implants placed in 18 rabbits. Results are shown as mean ± SD
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osteoblastic activity at the implant surface, and black ar-
rows show bluish staining corresponding to newly miner-
alized bone. The area above the line shows the parent old
bone (PB). Parent bone showed osteonal structures, lamel-
lar arrangement, and higher mineralization.
At 8 weeks of healing (Fig. 5), the bone contacting
the surfaces remained but decreased the density in
the 1 mm region. Remodeling led to the formation of
trabeculae linked to the parent subchondral bone,
mostly taking place in Ca-ion surfaces. An example of
this is marked with black arrows in Fig. 5c. Con-
versely, an example of newly formed bone near the
surfaces not linked to the parent bone trabeculae is
marked with asterisks in Fig. 5d.
Discussion
Upon implant placement, adsorption of proteins onto
the surface takes place immediately [25, 26]. The
characteristics of the protein corona formed at the sur-
face depend on the characteristics of the surface itself,
conditioning the evolution of the newly formed interface
and the implantation outcome. Ca-ions are known to
interact electrostatically with the oxide layer of Ti and
promote the advent of negatively charged protein resi-
dues to the surface [27]. Surface hydrophilicity is known
to increase the adsorption of fibrinogen and fibrin [28].
Nanotopography, in addition, stimulates platelet activa-
tion [29, 30].
The implant surfaces studied present both micron and
submicron topographical features. It has been previously
reported that additional nanofeatures emerge at Ca-ion
surfaces [26]. SEM visualization requires high vacuum
conditions, which modifies the physical state of the Ca-
ion surfaces with respect to ambient conditions, in
which Ca and Cl ions are dissociated and mostly re-
leased from the surface within the first seconds of
Fig. 4 Harris hematoxylin and Wheatley’s trichrome-stained ground sections of Ca-ion (a, inset a.1, c) and control (b, d) implant surfaces at 2
weeks of healing. PB, parent bone, NB, new bone. Scale bars 500 μm
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exposure to polar liquids such as water or blood [26].
SEM images of the Ca-ion washed surfaces showed
that the underlying topography remains unaltered. But
when exposed to blood plasma, Ca-ion surfaces have
been reported to induce surface clot formation, platelet
adsorption, and activation [4]. Activated platelets release
both osteogenic and angiogenic factors, calcium, and
phospholipids of the platelet membrane [8, 25, 31]. The
blood clot at the implant surface helps retain these fac-
tors, vectoring osteoprogenitor cell recruitment until
complete fibrinolysis takes place [32]. Osteoprogenitor
cells create a stable extracellular matrix for new bone
formation in contact with the implant surface [26].
Titanium superior osseointegration has been related to
its strong thrombogenicity [33, 34]. Ca ions are cofactor
intermediators in a number of events of the coagulation
cascade [9]. Considering this, here we sought to improve
our understanding on how calcium ions at titanium
implant surfaces contribute to accelerate the rate of
implant osseointegration from a surface proteomic
viewpoint.
The experiments conducted by Hong et al. [35] associ-
ated the higher thrombogenicity of titanium oxides to
the generation of high levels of activated FA12. The
serine protease FA12 starts the contact system or intrin-
sic pathway of coagulation, preferentially in contact with
negatively charged surfaces such as titanium oxides [36].
Hong and coworkers also suggested that titanium-
regulated FA12 in a particular way with respect to other
thrombogenic metal oxides. Our proteomic experiments
showed that the standard titanium surfaces used as con-
trol adsorb nearly four times more FA12 than Ca-ion
surfaces. Concomitantly FA12 activation triggers the
kallikrein system in an amplification loop. By-products
of this process, such as bradykinin, have been reported
to induce inflammation, thrombotic reactions, cell pro-
liferation, and vascular permeability [37, 38]. Conversely,
Ca-ion surfaces adsorbed over 180 times more FA10
than the control surfaces. FA10, also known as Stuart–
Prower factor, is the first factor of the common path of
coagulation. FA10 acts by cleaving prothrombin and,
with Ca ions, activates thrombin and allows the forma-
tion of the fibrin clot [25]. Coagulation at Ca-ion sur-
faces is thus governed by the common pathway of
coagulation, probably minimizing the contact activation
and amplification system that takes place at regular Ti
Fig. 5 Harris hematoxylin and Wheatley’s trichrome-stained ground sections of Ca-ion (a, c) and control (b, d) implant surfaces at 8 weeks of
healing. PB, parent bone; NB, new bone. Scale bars 500 μm
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surfaces. In other words, Ca-ion surfaces are more
thrombogenic than regular titanium surfaces and the
mechanisms of coagulation involved belong to the later
stages of the cascade, suggesting lower activation of the
complement cascade due to competition with the co-
agulation factors. Remarkably, abundant serum pro-
teins, such as albumin or fibronectin, were not
differentially adsorbed on the surfaces. An explanation
for this may be given according to the Vroman effect,
which showed that even though a protein is abundant
in the medium, it may have less affinity for a surface
than less abundant ones [5].
We used the same surface samples for protein adsorp-
tion and bone-integration studies. The only difference
being the presence or absence of surface Ca-ions. In this
work, we obtained similar osseointegration indexes to
those previously published in the rabbit [4]. Compared to
that study, we reported better BIC results of Ca ion sur-
faces already at 2 weeks of healing. There, the implant
shape was threaded and more invasive, while here we used
a smaller, non-threaded pin with no intended gap between
the implant surfaces and the implantation site. This sim-
pler geometry, closer to the parent bone, may have been
more favorable for the development of the regenerative
scaffold of fibrin, platelets, and growth factors at the sur-
face bridging the gap between the results obtained with or
without blood plasma application [4].
The differences found in osseointegration between Ca-
ion surfaces and regular surfaces can be associated with
the differential mechanisms of formation of the clot
around the two implant surfaces studied. The fibrin
structure of the peri-implant clot affects osteoconduc-
tion and new bone formation on implant surfaces [12].
The quick formation of a surface-bound stable clot at
Ca-ion surfaces acts as a chemotactic scaffold for the
continuous recruitment and migration of osteogenic
cells, which is a prerequisite for new bone formation
starting at the implant surface [13, 26, 39, 40]. The
structural proteins of the clot, with embedded growth
factors, serve as physical support for cell adhesion
and function, creating a more osteoconductive micro-
environment [31]. Indeed, Ca-ion prothrombotic sur-
faces created more bone at only 2 weeks of healing
but also established earlier connections to the parent
bone. The lateral stabilization of the implant is funda-
mental for the functional prosthetic loading. In a
study with representative bacterial strains of the oral
cavity leading to pervasive infections and in the pres-
ence of human serum and salivary proteins, Ca-ion
surfaces showed a significant reduction in adhesion
and biofilm formation [41]. These results and the
more osteogenic microenvironment generated by Ca-
ion modification at the implant surface may lead to
greater implant stability in the long term.
The decrease in bone volume density in 1 mm around
both implants at 8 weeks of implantation merits a dis-
cussion too. We found similar results using this animal
model in the past [4]. Woven unorganized bone around
the implants converts progressively into trabeculae that
join the implant surface with the subchondral bone. Re-
modeling gives rise to defined trabeculae. Therefore, in
both cases, the volume of bone around the implants de-
creases to the areas covered by the forming trabeculae
that stabilize the implants laterally. In other terms, there
is seemingly less bone, but it is mechanically more valu-
able. Indeed, the bone implant contact increases because
there is more bone covering the surfaces, extending the
trabeculae implant-end thickness. Concomitantly there
is less or no unorganized bone or bone debris in the 1
mm region around the implants, which has no relevant
mechanical role.
We found no acute inflammatory signals at either con-
trol or Ca-ion surfaces, even though both surfaces dis-
played a distinct set of proteins related to the innate
immune system: VTNC, SAA4, and CFAH at control Ti;
LYSC, PIP, and SAMP at Ca-ion. SAMP comprises five
subunits with two Ca-ion-binding positions and has
been related to immunological responses [42]. The pro-
teomics analysis was performed after incubation of the
surfaces for 3 h, for this period of incubation is enough
for the stabilization of the protein corona at regular ti-
tanium surfaces. However, the Ca-ion-modified surface
releases calcium ions over longer periods of time [4, 26],
varying thereby the chemical characteristics at the inter-
face and thus possibly the proteins adsorbed. To over-
come this limitation, longer protein adsorption studies
are underway. Changes in the calcium ion content of the
surface over time are expected to alter in turn the pro-
tein composition of the interface and will help to make
better understanding of its relationship with the differ-
ential osteogenic functions observed in vivo. The differ-
ences detected in protein adsorption may be an
explanation for the different regeneration mechanisms
found in the surfaces studied. From a strict scientific
viewpoint, there seems to be a correlation between hu-
man protein adsorption and rabbit osseointegration.
Therefore, the authors plan to pursue the experimenta-
tion unifying species and performing more in-depth ana-
lysis to clarify a potential causal relationship.
Conclusion
Ca-ion surfaces adsorbed overwhelmingly FA10, signal-
ing an advanced stage of the coagulation cascade and
suggesting a strong prothrombotic reaction at these sur-
faces. In vivo, Ca-ion surfaces stimulated more bone for-
mation around the implants than the standard implant
surfaces used as controls. These results are especially
relevant for the low quantity or quality of bone
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situations. Short or narrow implants with limited con-
tacting surfaces can be particularly benefited, paving the
way to less invasive surgeries, shorter healing times, and
overall lower intervention costs. Taken together, these
results shed more light in the relationship between sur-
face clot formation and implant osseointegration.
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